Low-dose dapsone, co-trimoxazole, and survival in Pneumocystis carinii primary prophylaxis.
Antinori
A
A
Murri
R
R
Ammassari
A
A
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000890:Anti-Infective Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003622:Dapsone / Q000009:adverse effects / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D011020:Pneumonia, Pneumocystis / Q000188:drug therapy* / Q000401:mortality; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000009:adverse effects / Q000627:therapeutic use*
D000890:Anti-Infective Agents; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D003622:Dapsone